GlassScriptPhysician profile
Panav Arjun Jha
NPI 1518535566
$479.50
in general payments reported to CMS, 2019-2025
16 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.50 · 2024: $62.45 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $112.52 | 2024-2025 | Monovisc, Orthovisc |
| Abbott Laboratories | $42.66 | 2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $42.40 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.64 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $37.27 | 2025 | Airsupra |
| Viiv Healthcare Company | $34.49 | 2025 | Dovato |
| Invivyd INC | $22.17 | 2025 | Pemgarda |
| Dynavax Technologies Corporation | $21.14 | 2025 | Heplisav-B |
| Gilead Sciences, INC. | $20.12 | 2025 | Biktarvy |
| Cranial Technologies, INC | $18.45 | 2024 | Doc Band |
| Abbvie INC. | $17.20 | 2025 | |
| Inspire Medical Systems, INC. | $15.59 | 2025 | Inspire |
| Lilly USA, LLC | $15.04 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $14.54 | 2025 | Repatha, Otezla |
| Agios Pharmaceuticals, INC. | $14.47 | 2025 | Pyrukynd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $12.80 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Panav Jha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.